Which topics – in terms of our corporate responsibility – are of particular significance to our long-term success? What expectations do our various stakeholders have of us? And in which areas do we contribute to a more sustainable development? In an effort to answer these questions, in 2018, we again conducted a materiality assessment, thereby fulfilling the requirements of the Global Reporting Initiative (GRI) and the German CSR Directive Implementation Act.
Realignment
To decide which topics to include in our report, we regularly conduct comprehensive materiality assessments. With our 2018 Corporate Responsibility (CR) Report, we took this process a step further: Looking at a broad range of issues, we considered the topics on which the business activities of our company have a material impact and, conversely, the impact these topics have on our business activities.
Materiality process
Identifying our topics
We first assessed the topics from previous materiality assessments in terms of their relevance before comparing them against the United Nations Sustainable Development Goals to determine the impact they have on these goals. As a next step, we discerned which additional sector-specific issues to include.
Analyzing external expectations and requirements
For each of the identified issues, we evaluated various external factors and assessed the impact they have on our business. Such aspects include relevant regulations, our competitors, the financial market, new requirements of non-governmental organizations (NGOs) on the chemical and pharmaceutical industries, and our economic setting. In conducting this analysis, we drew on relevant legislation, NGO reports and ESG ratings.
Analyzing our own impacts
As well as analyzing external factors, we also evaluated our company’s contribution to sustainable development. For each of the topics identified, we reviewed the following:
- the influence of the industries in which we operate
- our own positioning as a company
- the number of value chain steps affected
- the importance for our worldwide sites
Results of the analysis
We identified 35 topics that are of significance to our CR strategy and reporting and weighted them according to their relevance. The results were then discussed, validated and adopted by our CR Committee.
The issues rated as material form the focus of this CR Report. Since our stakeholders also expect information and transparency from us regarding less significant issues, we also report on these, albeit in less detail.
Identifying topics for non-financial disclosure
The German CSR Directive Implementation Act obliges us to review the “double materiality” of topics according to Section 289 (3) of the German Commercial Code. The principle of double materiality requires companies to disclose non-financial information when the following two criteria are met: Firstly, the information is necessary to understand the company’s business performance, business results and financial situation. And secondly, the information makes it possible to understand how the company’s business activities affect non-financial aspects.
We have reviewed the double materiality of the topics identified. Those that fall within the scope of this definition are marked in the materiality matrix. The topics are linked to the respective chapters in this report.
Material topics
Material issues in our value chain
The following table shows where our material issues fall within the value chain: upstream in our supply chain, in the course of our own activities, or downstream with our customers and patients. Moreover, we have listed the issues to show the breakdown of materiality by business sector and stakeholder group.
Product safety and quality
Material for:
Customers, Merck family, Shareholders, Government agencies, NGOs, Commercial and business associates
Material for:
Merck family, Shareholders, Government agencies, NGOs, Health systems, Patients
Material for:
Customers, Merck family, Shareholders, Federations and policy makers, Government agencies, NGOs, Commercial and business associates, Health systems, Patients
Material for:
Customers, Government agencies, Suppliers, Commercial and business associates, Communities
Ethical conduct
Material for:
Customers, Federations and policy makers, Government agencies, NGOs, Media, Scientists
Material for:
Merck family, Shareholders, Federations and policy makers, Government agencies, NGOs, Media, Suppliers, Scientists, Patients
Material for:
Government agencies, NGOs, Media, Suppliers, Scientists
Good business practice
Material for:
Employees, Merck family, Shareholders, Government agencies, NGOs, Suppliers, Commercial and business associates, Health systems, Competitors
Material for:
Customers, Federations and policy makers, Media, Commercial and business associates, Health systems, Patients
Material for:
Merck family, Employees, NGOs, Media, Communities
Material for:
Federations and policy makers, Government agencies, NGOs, Health systems, Patients
Material for:
Employees, Employee representatives, Merck family, Shareholders, Government agencies, Suppliers, Commercial and business associates, Customers
Material for:
Employees, Employee representatives, Suppliers, Commercial and business associates, Customers, Patients
Health for all
Material for:
NGOs, Media, Commercial and business associates, Health systems, Patients
Material for:
Merck family, Shareholders, NGOs, Media, Commercial and business associates, Health systems, Patients
Material for:
NGOs, Media, Commercial and business associates, Health systems, Patients, Communities, Competitors
Supply chain standards
Material for:
Customers, Merck family, Shareholders, Federations and policy makers, NGOs, Media, Suppliers, Competitors
Human rights
Material for:
Customers, Federations and policy makers, NGOs, Media, Suppliers, Communities, Employees
Sustainable products
Material for:
Customers, Scientists
Attractive employer
Material for:
Employees, Employee representatives, Merck family, Media
Material for:
Employees, Employee representatives, Merck family, Shareholders, Competitors
Material for:
Employees, Employee representatives
Material for:
Employees, Employee representatives
Material for:
Employees, Employee representatives
Material for:
Employees, Employee representatives, Government agencies
Material for:
Employees, Employee representatives
Technology
Material for:
Customers, Merck family, Shareholders, Scientists, Health systems, Patients
Material for:
Scientists, Commercial and business associates, Customers, Patients
Resource efficiency
Material for:
Government agencies, NGOs, Communities, Customers
Material for:
Government agencies, NGOs, Communities
Environmental protection
Material for:
Federations and policy makers, NGOs, Customers
Material for:
Customers, Federations and policy makers, Government agencies, NGOs, Media, Suppliers
Material for:
Employees, Shareholders, Merck family, Government agencies, Media
Material for:
Federations and policy makers, Government agencies, NGOs
Material for:
Federations and policy makers, Government agencies, NGOs